BRAIN Biotech AG
BNN
Rank in Stocks
#21677
Headquartered in Zwingenberg, Germany, and founded in 1993, BRAIN Biotech AG... Headquartered in Zwingenberg, Germany, and founded in 1993, BRAIN Biotech AG (renamed from B.R.A.I.N. Biotechnology Research and Information Network AG in April 2021) specializes in the discovery, development, production, and commercialization of advanced biological solutions. These include enzymes, biocatalysts, microorganisms, and naturally derived active compounds, catering to the chemical industry across Germany, the United States, France, the Netherlands, and the United Kingdom. The company operates through two distinct segments: BioScience and BioIndustrial. The BioScience division is dedicated to uncovering and developing bioactive natural ingredients, such as sugar alternatives, taste modifiers, and other nature-based active components for diverse applications in the food, animal nutrition, skincare, cosmetics, and broader chemical sectors. Concurrently, the BioIndustrial segment focuses on identifying and optimizing enzymes and biocatalysts critical for manufacturing food and beverages, medical wound care products, lubricants, as well as for starch processing and bioethanol production. This segment also engineers microorganisms to serve as functional biomass for optimizing industrial manufacturing processes, converting greenhouse gas CO2 into a valuable industrial raw material, and facilitating the extraction of precious and rare earth metals. Furthermore, BRAIN Biotech AG has established strategic alliances with AnalytiCon Discovery GmbH and Roquette to jointly develop natural sweeteners and enhanced sweet taste solutions.
Share Price
$2.94
Last synced: 2026-11-09
Market Cap
$64.24M
Change (1 day)
0.67%
Change (1 year)
7.09%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade BRAIN Biotech AG (BNN)
Category
Healthcare
EPS for BRAIN Biotech AG (BNN)
EPS as of June 2026 TTM: $-0.74
According to BRAIN Biotech AG's latest financial reports, its current EPS (TTM) is $-0.74. At the end of 2025 the company had an EPS of $-0.63, a decrease compared to its 2024 EPS of $-0.57.
EPS history for BRAIN Biotech AG from 2012 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.74 | 16.83% |
| 2025 | $-0.63 | 11.51% |
| 2024 | $-0.57 | 41.24% |
| 2023 | $-0.40 | 36.79% |
| 2022 | $-0.29 | 1.62% |
| 2021 | $-0.29 | -52.53% |
| 2020 | $-0.61 | -3.56% |
| 2019 | $-0.63 | 18.43% |
| 2018 | $-0.53 | -22.13% |
| 2017 | $-0.69 | -37.15% |
| 2016 | $-1.09 | 116.97% |
| 2015 | $-0.50 | -0.49% |
| 2014 | $-0.51 | 6.74% |
| 2013 | $-0.47 | -23.28% |
| 2012 | $-0.62 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -2,227.72% |
US
|
|
| $-7.07 | 860.60% |
US
|
|
| $-5.29 | 618.75% |
AU
|
|
| $12.88 | -1,850.01% |
BE
|
|
| $21.56 | -3,029.35% |
NL
|
Questions about BRAIN Biotech AG's earnings per share (EPS)
What is BRAIN Biotech AG's earnings per share (EPS)?
BRAIN Biotech AG's earnings per share (EPS) over the last twelve months is $-0.74, as of Jun 2026.
What was BRAIN Biotech AG's earnings per share (EPS) in 2025?
In 2025, BRAIN Biotech AG's earnings per share (EPS) was $-0.63, compared with $-0.57 in 2024.
How has BRAIN Biotech AG's earnings per share (EPS) changed since 2020?
From 2020 to 2025, BRAIN Biotech AG's earnings per share (EPS) was highest in 2022 ($-0.29) and lowest in 2025 ($-0.63).
How does BRAIN Biotech AG's earnings per share (EPS) compare with similar companies?
BRAIN Biotech AG's earnings per share (EPS) ($-0.74) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.